Three very small Asian issuers and one blank check company listed in the US this past week, though the biggest headlines came from a sizable launch and notable new filings.Energy equipment and services provider Flowco (FLOC) launched the year’s first...read more
Zhengye Biotechnology Holding, a Chinese provider of veterinary vaccines with a focus on livestock, raised $6 million by offering 1.5 million shares at $4, the low end of the range of $4 to $5. Through its operating entity, the company focuses on the research,...read more
Zhengye Biotechnology Holding, a Chinese provider of veterinary vaccines with a focus on livestock, raised the proposed deal size for its upcoming IPO on Thursday.The Jilin, China-based company now plans to raise $7 million by offering 1.5 million shares at a...read more
Zhengye Biotechnology Holding, a Chinese provider of veterinary vaccines with a focus on livestock, announced terms for its IPO on Friday.The Jilin, China-based company plans to raise $6 million by offering 1.3 million shares at a price range of $4 to $5. At...read more
US IPO Weekly Recap: Flowco launches first major IPO of 2025 as Smithfield, others join the pipeline
Three very small Asian issuers and one blank check company listed in the US this past week, though the biggest headlines came from a sizable launch and notable new filings.Energy equipment and services provider Flowco (FLOC) launched the year’s first...read more
Chinese animal health company Zhengye Biotechnology prices US IPO at the $4 low end
Zhengye Biotechnology Holding, a Chinese provider of veterinary vaccines with a focus on livestock, raised $6 million by offering 1.5 million shares at $4, the low end of the range of $4 to $5. Through its operating entity, the company focuses on the research,...read more
Chinese animal health company Zhengye Biotechnology ups share offering by 20% ahead of $7 million US IPO
Zhengye Biotechnology Holding, a Chinese provider of veterinary vaccines with a focus on livestock, raised the proposed deal size for its upcoming IPO on Thursday.The Jilin, China-based company now plans to raise $7 million by offering 1.5 million shares at a...read more
Chinese animal health company Zhengye Biotechnology sets terms for $6 million US IPO
Zhengye Biotechnology Holding, a Chinese provider of veterinary vaccines with a focus on livestock, announced terms for its IPO on Friday.The Jilin, China-based company plans to raise $6 million by offering 1.3 million shares at a price range of $4 to $5. At...read more